Seneca House Advisors’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$371K Sell
705
-23
-3% -$12.9K 0.13% 79
2026
Q1
$409K Sell
728
-35
-5% -$22.4K 0.16% 76
2025
Q4
$516K Buy
763
+2
+0.3% +$1.36K 0.19% 65
2025
Q3
$486K Sell
761
-128
-14% -$77.7K 0.2% 61
2025
Q2
$477K Sell
889
-18
-2% -$8.61K 0.2% 57
2025
Q1
$381K Sell
907
-9
-1% -$3.91K 0.16% 64
2024
Q4
$379K Sell
916
-48
-5% -$21.1K 0.15% 67
2024
Q3
$487K Sell
964
-123
-11% -$59.8K 0.21% 58
2024
Q2
$530K Sell
1,087
-22
-2% -$11K 0.23% 54
2024
Q1
$599K Sell
1,109
-162
-13% -$88.5K 0.26% 55
2023
Q4
$705K Buy
1,271
+16
+1% +$7.51K 0.33% 46
2023
Q3
$555K Sell
1,255
-12
-0.9% -$5.98K 0.29% 53
2023
Q2
$636K Sell
1,267
-23
-2% -$11K 0.32% 54
2023
Q1
$645K Sell
1,290
-13
-1% -$6.22K 0.33% 52
2022
Q4
$532K Sell
1,303
-74
-5% -$28.7K 0.29% 56
2022
Q3
$449K Buy
1,377
+45
+3% +$16.5K 0.33% 58
2022
Q2
$467K Buy
1,332
+12
+0.9% +$4.89K 0.31% 62
2022
Q1
$722K Buy
1,320
+55
+4% +$28.9K 0.38% 52
2021
Q4
$833K Buy
1,265
+152
+14% +$95.4K 0.44% 47
2021
Q3
$692K Buy
+1,113
New +$748K 0.42% 50

Other funds holding IDXX

Seneca House Advisors's IDXX Position: Q2 2026 in Review

Seneca House Advisors reduced its Idexx Laboratories (IDXX) stake by 3.2% in Q2 2026, selling an estimated $12.9K and leaving 705 shares worth $371K. The position accounts for 0.13% of the portfolio, ranked #79.

Seneca House Advisors first reported a position in IDXX in Q3 2021 and has held it in 20 quarters since. The position peaked at $833K in Q4 2021. 1,302 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Seneca House Advisors held 705 shares of Idexx Laboratories worth $371K as of Q2 2026.
  • Seneca House Advisors sold 23 Idexx Laboratories shares in Q2 2026, an estimated $12.9K.
  • Idexx Laboratories made up 0.13% of Seneca House Advisors's portfolio in Q2 2026, its #79 holding.
  • Seneca House Advisors first reported a position in Idexx Laboratories in Q3 2021 and has held it in 20 quarters since.
  • Seneca House Advisors's Idexx Laboratories position peaked at $833K in Q4 2021.
  • 1,302 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Seneca House Advisors's 13F filing for Q2 2026, filed 31 Jul 2026.